ClearPoint Neuro (CLPT) Cash & Equivalents Growth (1y) (2012 - 2026)
ClearPoint Neuro (CLPT) Cash & Equivalents Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | -22.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -7.71% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 23.57% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 156.03% |
| 10 | ClearPoint Neuro | 398.59 Mn | 362.99 Mn | 7.76 Mn | 187.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 187.40% |
| Dec 31, 2025 | 128.43% |
| Sep 30, 2025 | 77.07% |
| Jun 30, 2025 | 26.35% |
| Mar 31, 2025 | -65.01% |
| Dec 31, 2024 | -13.12% |
| Sep 30, 2024 | -11.22% |
| Jun 30, 2024 | 23.94% |
| Mar 31, 2024 | 62.39% |
| Dec 31, 2023 | -16.20% |
| Sep 30, 2023 | 29.86% |
| Jun 30, 2023 | 12.77% |
| Mar 31, 2023 | -56.10% |
| Dec 31, 2022 | -48.96% |
| Sep 30, 2022 | -67.54% |
| Jun 30, 2022 | -61.80% |
| Mar 31, 2022 | -23.44% |
| Dec 31, 2021 | 169.17% |
| Sep 30, 2021 | 293.12% |
| Jun 30, 2021 | 283.76% |